Risk-Based lung cancer screening: A systematic review
- PMID: 32721652
- DOI: 10.1016/j.lungcan.2020.07.007
Risk-Based lung cancer screening: A systematic review
Abstract
Lung cancer remains the leading cause of cancer related deaths worldwide. Lung cancer screening using low-dose computed tomography (LDCT) has been shown to reduce lung cancer specific mortality. In 2013, the United States Preventive Services Task Force (USPSTF) recommended annual lung cancer screening with LDCT for smokers aged between 55 years to 80 years, with at least 30 pack-years of smoking exposure that currently smoke or who have quit smoking within 15 years. Risk-based lung cancer screening is an alternative approach that defines screening eligibility based on the personal risk of individuals. Selection of individuals for lung cancer screening based on their personal lung cancer risk has been shown to improve the sensitivity and specificity associated with the eligibility criteria of the screening program as compared to the 2013 USPSTF criteria. Numerous risk prediction models have been developed to estimate the lung cancer risk of individuals incorporating sociodemographic, smoking, and clinical risk factors associated with lung cancer, including age, smoking history, sex, race/ethnicity, personal and family history of cancer, and history of emphysema and chronic obstructive pulmonary disease (COPD), among others. Some risk prediction models include biomarker information, such as germline mutations or protein-based biomarkers as independent risk predictors, in addition to clinical, smoking, and sociodemographic risk factors. While, the majority of lung cancer risk prediction models are suitable for selecting high-risk individuals for lung cancer screening, some risk models have been developed to predict the probability of malignancy of screen-detected solidary pulmonary nodules or to optimize the screening frequency of eligible individuals by incorporating past screening findings. In this systematic review, we provide an overview of existing risk prediction models and their applications to lung cancer screening. We discuss potential strengths and limitations of lung cancer screening using risk prediction models and future research directions.
Keywords: Computed tomography; Early diagnosis; Lung neoplasms; Pulmonary nodules; Risk assessment; Risk prediction; Screening; Statistical model.
Copyright © 2020. Published by Elsevier B.V.
Similar articles
-
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.JAMA. 2021 Mar 9;325(10):988-997. doi: 10.1001/jama.2021.1077. JAMA. 2021. PMID: 33687469 Free PMC article.
-
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: A Collaborative Modeling Study for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-2. PMID: 33750088 Free Books & Documents. Review.
-
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117. JAMA. 2021. PMID: 33687470
-
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr. PLoS Med. 2017. PMID: 28376113 Free PMC article.
-
Lung Cancer Screening.Med Clin North Am. 2022 Nov;106(6):1041-1053. doi: 10.1016/j.mcna.2022.07.007. Epub 2022 Oct 4. Med Clin North Am. 2022. PMID: 36280331 Review.
Cited by
-
Acceptability of Personalized Lung Cancer Screening Program Among Primary Care Providers.Cancer Prev Res (Phila). 2024 Feb 2;17(2):51-57. doi: 10.1158/1940-6207.CAPR-23-0359. Cancer Prev Res (Phila). 2024. PMID: 38212272 Free PMC article.
-
Development of Lung Cancer Risk Prediction Machine Learning Models for Equitable Learning Health System: Retrospective Study.JMIR AI. 2024 Sep 11;3:e56590. doi: 10.2196/56590. JMIR AI. 2024. PMID: 39259582 Free PMC article.
-
Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.Curr Opin Pulm Med. 2023 Jul 1;29(4):232-238. doi: 10.1097/MCP.0000000000000974. Epub 2023 May 16. Curr Opin Pulm Med. 2023. PMID: 37191171 Free PMC article. Review.
-
LINC00467: an oncogenic long noncoding RNA.Cancer Cell Int. 2022 Oct 7;22(1):303. doi: 10.1186/s12935-022-02733-5. Cancer Cell Int. 2022. PMID: 36203193 Free PMC article. Review.
-
Exosome-delivered circSATB2 targets the miR-330-5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells.Thorac Cancer. 2022 Nov;13(21):3007-3017. doi: 10.1111/1759-7714.14652. Epub 2022 Sep 23. Thorac Cancer. 2022. PMID: 36148757 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
